Hycells Recruitment | Continuous Exploration and Innovation
Release Date:
2026-01-05 11:14
About Hycells Biology
Hycells Biotechnology is a biotech company specializing in primary cell technologies and innovative solutions. Headquartered in Wuxi, the company operates dual hubs in Wuxi and Shanghai: the Wuxi center focuses on product R&D, manufacturing, and commercialization, while the Shanghai center concentrates on primary cell preparation and technical services. The company is committed to providing domestically developed, proprietary tools and technologies for biopharmaceutical R&D and manufacturing. Leveraging its independent technology platform, it has launched a comprehensive portfolio of products, including primary immune cells, stem cells, primary animal cells, flow cytometry antibodies for CAR-positive rate detection, immune cell expansion culture media, stem cell expansion and differentiation media, cryopreservation solutions, and cell culture additives. In addition, drawing on its rich resources and technological strengths in primary cells, the company has expanded into in vitro efficacy evaluation, drug immunogenicity assessment, and in vitro blood toxicity testing services. Several of its products and services have already broken the long-standing monopoly of foreign suppliers, achieving domestic substitution and even surpassing their performance.
The company has always adhered to the principle of “ Talent as the foundation, quality first, and innovation as the core. adheres to the core values of “”, is driven by technological innovation, sets new industry standards for domestic innovation, and provides a solid foundation for the development and global advancement of China’s innovative medicines.
Job Openings
Field: Biopharmaceuticals
Core Product Line: Primary Cell Products and Services
Staff size: 50–100 people
Main locations: Wuxi, Shanghai
Position 1: PM (R&D Project Management) (Shanghai)
Job Responsibilities:
1. Communicate with the BD and FA departments to finalize technical requirements for client projects and ensure the smooth execution of commercial tasks;
2. Responsible for full lifecycle project management, tracking and maintaining the project schedule, and facilitating project communication and coordination;
3. Coordinate internally across departments, regularly convene internal CMC meetings to track progress and the completion of action items, and ensure the smooth execution of all projects;
4. Communicate with external clients, coordinate and manage issues arising in client projects, and provide timely feedback to internal departments.
5. Responsible for project execution management, identifying and resolving issues arising during project implementation, organizing project team members to conduct research, and proposing feasible and rational solutions;
6. Prepare internal and external meeting minutes, project progress summaries, and business correspondence during the project lifecycle;
7. Actively maintain customer relationships and ensure a strong, collaborative partnership between the company and its clients;
8. Complete other tasks assigned by superior leaders.
Job Requirements:
1. At least three years of work experience in the biopharmaceutical industry at the bachelor’s level and at least one year at the master’s level, with a minimum of one year of project management experience; familiar with the biopharmaceutical industry; CDMO/CRO experience is preferred.
2. Possess a strong service mindset, be customer-centric, proactive, results-oriented, and able to work hard and endure hardship;
3. Prior experience in R&D, quality, manufacturing, project management, regulatory affairs, and registration at biopharmaceutical companies is preferred.
4. Possess strong professional ethics, excellent organizational and coordination skills, and the ability to integrate resources; adept at communication, negotiation, and public relations.
5. Strong ability to work independently and high resilience; proficient in using project management tools;
6. Strong English listening, speaking, reading, and writing skills.
Position 2: QC Specialist (Shanghai)
Related News
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how He Yousheng proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.
Recently, the research team led by Researcher Bian Yingjie at the Guangzhou National Laboratory, in collaboration with partners from Sun Yat-sen University, published a study titled “Iron overload in the tumor microenvironment induces CD8⁺ T cell ferroptosis and dysfunction” in the internationally renowned academic journal Nature Communications.
Hycells Recruitment | Never Stop Exploring, Never Stop Innovating
The company consistently upholds its core values of “people‑centricity, quality first, and innovation as the foundation,” remains driven by technological innovation, and sets new industry benchmarks for domestic innovation, thereby laying a solid foundation for the development and global advancement of China’s innovative pharmaceutical sector.
The HiXpan® NK Serum-Free Culture Kit, Version 3.0, is manufactured in strict compliance with GMP standards, and its production system fully adheres to relevant guidelines and regulations, including the “818 Requirements,” positioning it for pharmaceutical‑grade manufacturing and applications.
Contact Us
Phone: 021-36696819
Mobile phone:13061948224(Ms. Yu)
Email:monika@hys-bio.com
Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City
Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai
Official Website
WeChat Official Account
Message Board